Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 33342-273

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 33342-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15mg-100s-carton (Cyclobenzaprine 15mg 100s Cart)

Cyclobenzaprine Hydrochloride 15 mg Extended-Release Capsules packaging label from Macleods Pharmaceuticals Limited. The label indicates a 100-capsule blister card pack (10 x 10 unit-dose capsules). It includes dosage strength, manufacturing information, storage instructions, and a barcode.*

FDA Label Image

15mg-60s (Cyclobenzaprine 15mg 60s Cont)

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, 15 mg, USP. The package contains 60 capsules, manufactured by Macleods Pharmaceuticals Ltd. in India, and labeled for Macleods Pharma USA, Inc. The label includes dosage strength and storage instructions, with a section marked OPZ AREA and various barcodes.*

FDA Label Image

30mg-100s-carton (Cyclobenzaprine 30mg 100s Cart)

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, USP 30 mg by Macleods Pharmaceuticals Limited. The package contains 100 capsules (10 x 10 unit-dose capsules) and includes manufacturer and distributor information for Macleods Pharma USA, Inc. The label also shows standard storage advice and a barcode.*

FDA Label Image

30mg-60s (Cyclobenzaprine 30mg 60s Cont)

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, USP 30 mg, manufactured by Macleods Pharmaceuticals Limited. The label shows a 60-capsule package, with instructions to store at controlled room temperature and dispense in a light-resistant container. It includes the NDC 33342-273-09 and specifies use for adults with dosage direction noted.*

FDA Label Image

Structure (Cyclobenzaprine Chemical Structure)

Chemical structure of Cyclobenzaprine Hydrochloride showing its molecular formula representation with three fused rings and side chain elements as part of the displayed compound*

FDA Label Image

Step-4 (Cyclobenzaprine Step 4)

An illustration showing a spoon containing a small amount of granulated or powdered substance. The drawing is simple, black and white, and focuses on the spoon's side view with a heap of powder on it.*

FDA Label Image

Step-5 (Cyclobenzaprine Step 5)

An instructional illustration showing a person holding a capsule marked with the word "TOP," demonstrating how to identify or handle the capsule correctly. The image likely relates to the proper orientation or administration of Cyclobenzaprine Hydrochloride extended-release capsules.*

FDA Label Image

Step-6 (Cyclobenzaprine Step 6)

An instructional illustration showing a close-up of two hands demonstrating how to twist or open a small cylindrical capsule or container labeled with the word 'TOP.' One hand holds the bottom part steady while the other hand twists the top part counterclockwise.*

FDA Label Image

Step-7 (Cyclobenzaprine Step 7)

An instructional illustration depicting a hand opening a capsule and pouring its contents onto a spoon, demonstrating how to empty the extended-release capsule before administration.*

FDA Label Image

Step-8 (Cyclobenzaprine Step 8)

An illustration showing a woman about to take medication by mouth using a spoon. The image likely demonstrates oral administration of a drug.*

FDA Label Image

Step-9 (Cyclobenzaprine Step 9)

An illustration of a person drinking a glass of water, likely demonstrating proper administration of an oral medication such as Cyclobenzaprine Hydrochloride extended-release capsule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.